Your browser version may not work well with NCBI's Web applications. More information here...
1: Hinyokika Kiyo. 1992 May;38(5):629-32.Links

[Bacteriological and clinical studies on levofloxacin in male gonococcal urethritis]

[Article in Japanese]

Department of Clinical Laboratory, Tokyo Kyosai Hospital.

We performed basic and clinical studies in male gonococcal urethritis on a new oral antimicrobial agent, levofloxacin (LVFX, DR-3355), a new quinolone derivative. The antibacterial activity of LVFX against clinical strains of Neisseria gonorrhoeae was roughly comparable to that of ofloxacin, and ciprofloxacin. LVFX was administered to 10 males with gonococcal urethritis, 200 mg twice a day (8 cases) or 100 mg twice a day for 3 days (2 cases). Clinical evaluation was made according to the criteria of the Japanese UTI Committee. Overall efficacy rate was 100% (10/10). In the complication of chlamydia trachomatis (2 cases), efficacy rate was 100% (2/2). No subjective or objective adverse reactions occurred.

PMID: 1609678 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Ciprofloxacin (Cipro® , Cipro® XR, Proquin® XR)

    Ciprofloxacin is used to treat or prevent certain infections caused by bacteria. Ciprofloxacin is also used to treat or prevent anthrax (a serious infection that may be spread on purpose as part of a bioterror attack) in...

  • Ofloxacin (Floxin® )

    Ofloxacin is used to treat certain infections including bronchitis, pneumonia, and infections of the skin, bladder, urinary tract, reproductive organs, and prostate (a male reproductive gland). Ofloxacin is in a class of...

  • Levofloxacin (Levaquin® )

    Levofloxacin is used to treat certain infections such as pneumonia chronic bronchitis and sinus, urinary tract, kidney, prostate (a male reproductive gland), and skin infections. Levofloxacin is also used to prevent anth...